HER2 screening recommended for lung adenocarcinoma patients
Researchers highlight the importance of testing for HER2 mutations in patients with non-small-cell lung cancer, adding to evidence that supports the use of HER2-targeted drugs in this population.
Source: MedWire News - Lung Cancer - Category: Cancer & Oncology Source Type: news
More News: Adenocarcinoma | Cancer | Cancer & Oncology | HER2 | Lung Cancer | Non-Small Cell Lung Cancer